Trial Profile
A Randomized Phase 2 Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium -Mediated Photodynamic Therapy for Patients With Epitheliod Malignant Pleural Mesothelioma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2023
Price :
$35
*
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Carcinoma; Malignant-mesothelioma
- Focus Therapeutic Use
- Acronyms MPM-PDT
- 31 Aug 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 31 Aug 2023 Planned primary completion date changed from 1 Jun 2023 to 1 May 2024.
- 25 Jul 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.